StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc (WST) stock

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3031% above fair value
$404.02−10.10 (-2.44%)

Close on Nov 18, 2026Market cap $28.14BP/E 45.3Yield 0.21%

West Pharmaceutical Services revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

West Pharmaceutical Services's revenue for the twelve months ending Sep 30, 2026 was $3.40B, up 12.6% year over year. For fiscal 2025 it was $3.07B, up 6.3% from the year before. Over ten years it grew 8.2% a year on average. The highest annual figure on record is $3.07B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.07B+6.3%
FY2024Dec 31, 2024$2.89B-1.9%
FY2023Dec 31, 2023$2.95B+2.2%
FY2022Dec 31, 2022$2.89B+2.0%
FY2021Dec 31, 2021$2.83B+31.9%
FY2020Dec 31, 2020$2.15B+16.7%
FY2019Dec 31, 2019$1.84B+7.1%
FY2018Dec 31, 2018$1.72B+7.4%
FY2017Dec 31, 2017$1.60B+6.0%
FY2016Dec 31, 2016$1.51B+7.8%
FY2015Dec 31, 2015$1.40B-1.5%
FY2014Dec 31, 2014$1.42B+3.9%
FY2013Dec 31, 2013$1.37B+8.1%
FY2012Dec 31, 2012$1.27B+6.2%
FY2011Dec 31, 2011$1.19B+7.9%
FY2010Dec 31, 2010$1.10B+4.6%
FY2009Dec 31, 2009$1.06B+0.4%
FY2008Dec 31, 2008$1.05B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$874.50M+8.7%
Q2 FY2026Jun 30, 2026$872.30M+13.8%
Q1 FY2026Mar 31, 2026$844.90M+21.0%
Q4 FY2025Dec 31, 2025$805.00M+7.5%
Q3 FY2025Sep 30, 2025$804.60M+7.7%
Q2 FY2025Jun 30, 2025$766.50M+9.2%
Q1 FY2025Mar 31, 2025$698.00M+0.4%
Q4 FY2024Dec 31, 2024$748.80M+2.3%
Q3 FY2024Sep 30, 2024$746.90M-0.1%
Q2 FY2024Jun 30, 2024$702.10M-6.9%
Q1 FY2024Mar 31, 2024$695.40M-3.0%
Q4 FY2023Dec 31, 2023$732.00M+3.3%
Q3 FY2023Sep 30, 2023$747.40M+8.8%
Q2 FY2023Jun 30, 2023$753.80M-2.3%
Q1 FY2023Mar 31, 2023$716.60M-0.5%
Q4 FY2022Dec 31, 2022$708.70M-3.0%
Q3 FY2022Sep 30, 2022$686.90M-2.8%
Q2 FY2022Jun 30, 2022$771.30M+6.6%
Q1 FY2022Mar 31, 2022$720.00M+7.4%
Q4 FY2021Dec 31, 2021$730.80M+26.0%
Q3 FY2021Sep 30, 2021$706.50M+28.9%
Q2 FY2021Jun 30, 2021$723.60M+37.3%
Q1 FY2021Mar 31, 2021$670.70M+36.5%
Q4 FY2020Dec 31, 2020$580.20M+23.3%
Q3 FY2020Sep 30, 2020$548.00M+20.1%
Q2 FY2020Jun 30, 2020$527.20M+12.2%
Q1 FY2020Mar 31, 2020$491.50M+10.8%
Q4 FY2019Dec 31, 2019$470.60M+11.4%
Q3 FY2019Sep 30, 2019$456.10M+5.7%
Q2 FY2019Jun 30, 2019$469.70M+5.0%
Q1 FY2019Mar 31, 2019$443.50M+6.7%
Q4 FY2018Dec 31, 2018$422.50M+1.7%
Q3 FY2018Sep 30, 2018$431.70M+8.4%
Q2 FY2018Jun 30, 2018$447.50M+12.6%
Q1 FY2018Mar 31, 2018$415.70M+7.2%
Q4 FY2017Dec 31, 2017$415.60M+8.7%
Q3 FY2017Sep 30, 2017$398.20M–
Q2 FY2017Jun 30, 2017$397.60M–
Q1 FY2017Mar 31, 2017$387.70M–
Q4 FY2016Dec 31, 2016$382.30M–

More West Pharmaceutical Services figures

See a number that looks wrong?